These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene editing prospects for treating inherited retinal diseases. Benati D; Patrizi C; Recchia A J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428 [TBL] [Abstract][Full Text] [Related]
5. Challenges to Gene Editing Approaches in the Retina. Bonillo M; Pfromm J; Fischer MD Klin Monbl Augenheilkd; 2022 Mar; 239(3):275-283. PubMed ID: 35316854 [TBL] [Abstract][Full Text] [Related]
6. In vivo application of base and prime editing to treat inherited retinal diseases. Jo DH; Bae S; Kim HH; Kim JS; Kim JH Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547 [TBL] [Abstract][Full Text] [Related]
7. Gene Therapy for Inherited Retinal Degeneration. Arbabi A; Liu A; Ameri H J Ocul Pharmacol Ther; 2019 Mar; 35(2):79-97. PubMed ID: 30688548 [TBL] [Abstract][Full Text] [Related]
8. Dawn of ocular gene therapy: implications for molecular diagnosis in retinal disease. Zaneveld J; Wang F; Wang X; Chen R Sci China Life Sci; 2013 Feb; 56(2):125-33. PubMed ID: 23393028 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases. Lin WV; Stout JT; Weng CY Int Ophthalmol Clin; 2019; 59(1):3-13. PubMed ID: 30585915 [No Abstract] [Full Text] [Related]
10. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities. Chien Y; Hsiao YJ; Chou SJ; Lin TY; Yarmishyn AA; Lai WY; Lee MS; Lin YY; Lin TW; Hwang DK; Lin TC; Chiou SH; Chen SJ; Yang YP J Nanobiotechnology; 2022 Dec; 20(1):511. PubMed ID: 36463195 [TBL] [Abstract][Full Text] [Related]
11. Genome Surgery and Gene Therapy in Retinal Disorders. Chan L; Mahajan VB; Tsang SH Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518 [TBL] [Abstract][Full Text] [Related]
12. CRISPR in the Retina: Evaluation of Future Potential. Cho GY; Justus S; Sengillo JD; Tsang SH Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158 [TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 genome surgery for retinal diseases. Xu CL; Park KS; Tsang SH Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877 [TBL] [Abstract][Full Text] [Related]
14. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo. Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513 [TBL] [Abstract][Full Text] [Related]
15. Gene editing technology: Towards precision medicine in inherited retinal diseases. Ballios BG; Pierce EA; Huckfeldt RM Semin Ophthalmol; 2021 May; 36(4):176-184. PubMed ID: 33621144 [No Abstract] [Full Text] [Related]